Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease, according to Weill Cornell Medicine researchers.
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects.
A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.
The White House has recognized six Cornell faculty members, three from the Ithaca campus and three from Weill Cornell Medicine, with 2025 Presidential Early Career Awards for Scientists and Engineers. The awards were announced Jan. 14.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
Novo Nordisk’s top executive is testifying before senators today over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both soars.
John August, program director of healthcare labor relations at Cornell University’s School of Industrial and Labor Relations, said he expects the healthcare consolidation trend to continue.
Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
